|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases transport |
ISO |
ABCC4 protein results in increased transport of Enalapril |
CTD |
PMID:17939016 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Ace |
angiotensin I converting enzyme |
decreases activity multiple interactions increases expression |
ISO EXP |
Enalapril results in decreased activity of ACE protein Enalapril inhibits the reaction [Dexamethasone results in increased expression of ACE protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of ACE protein]]; Enalapril inhibits the reaction [Formaldehyde results in increased expression of ACE protein] ACE gene polymorphism affects the susceptibility to [Enalapril co-treated with Sodium Chloride]; ACE gene polymorphism inhibits the reaction [[Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form] Enalapril results in increased expression of ACE mRNA Enalapril inhibits the reaction [Streptozocin results in increased expression of ACE mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of ACE protein]; Enalapril promotes the reaction [Folic Acid results in increased expression of ACE mRNA] |
CTD |
PMID:15728788 PMID:15816410 PMID:20679179 PMID:20829712 PMID:23733546 PMID:28973481 PMID:30940551 PMID:36706861 More...
|
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
EXP |
Enalapril results in decreased expression of ACTA2 protein |
CTD |
PMID:19349682 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
decreases expression |
EXP |
Enalapril results in decreased expression of ACVRL1 protein |
CTD |
PMID:12883979 |
|
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
Enalapril results in increased expression of ADIPOQ protein |
CTD |
PMID:25037058 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
increases expression |
EXP |
Enalapril results in increased expression of ADRB1 protein |
CTD |
PMID:7586371 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Agt |
angiotensinogen |
decreases activity affects response to substance increases expression decreases response to substance multiple interactions decreases expression |
EXP ISO |
Enalapril results in decreased activity of AGT protein modified form AGT gene alternative form affects the susceptibility to Enalapril; AGT protein polymorphism affects the susceptibility to Enalapril Enalapril results in increased expression of AGT mRNA Enalapril results in decreased susceptibility to AGT protein modified form Enalapril affects the reaction [chymostatin results in decreased susceptibility to AGT protein modified form]; Enalapril inhibits the reaction [Cyclosporine results in increased expression of AGT protein]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of AGT protein] Enalapril results in decreased expression of AGT protein modified form [Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form; ACE gene polymorphism inhibits the reaction [[Enalapril co-treated with Sodium Chloride] results in increased susceptibility to AGT protein modified form]; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone] Enalapril results in decreased expression of AGT mRNA |
CTD |
PMID:1330361 PMID:2474097 PMID:6319675 PMID:12003776 PMID:12911327 PMID:14659064 PMID:16685205 PMID:18300870 PMID:18679781 PMID:18796534 PMID:19114890 PMID:20829712 PMID:21602471 More...
|
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
increases expression multiple interactions decreases expression affects expression |
EXP ISO |
Enalapril results in increased expression of AGTR1A mRNA Enalapril inhibits the reaction [Dexamethasone results in increased expression of AGTR1 protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of AGTR1 protein]]; Enalapril inhibits the reaction [Formaldehyde results in increased expression of AGTR1 protein] Enalapril results in decreased expression of AGTR1A mRNA Enalapril inhibits the reaction [Cyclosporine results in decreased expression of AGTR1A mRNA] Enalapril affects the expression of AGTR1A mRNA |
CTD |
PMID:14659064 PMID:18403896 PMID:18765277 PMID:18796534 PMID:30940551 PMID:36706861 More...
|
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
increases expression decreases expression |
EXP |
Enalapril results in increased expression of AGTR2 mRNA Enalapril results in decreased expression of AGTR2 mRNA |
CTD |
PMID:9740612 PMID:18403896 PMID:18765277 |
|
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Enalapril promotes the reaction [Isoproterenol results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18806606 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of ALPL mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Ang |
angiogenin |
decreases expression |
ISO |
Enalapril results in decreased expression of ANG protein |
CTD |
PMID:3038326 |
|
NCBI chr15:26,786,233...26,796,883
|
|
G |
Angpt2 |
angiopoietin 2 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in increased expression of ANGPT2 mRNA] |
CTD |
PMID:19958114 |
|
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with Atorvastatin co-treated with Valsartan] results in decreased expression of APOE protein Enalapril inhibits the reaction [APOE gene mutant form results in decreased abundance of Antioxidants]; Enalapril inhibits the reaction [APOE gene mutant form results in increased abundance of Cholesterol] |
CTD |
PMID:19603250 PMID:25037058 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Atf2 |
activating transcription factor 2 |
increases expression |
EXP |
Enalapril results in increased expression of ATF2 protein |
CTD |
PMID:15531746 |
|
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
EXP |
Enalapril results in increased expression of ATP1A2 mRNA; Enalapril results in increased expression of ATP1A2 protein |
CTD |
PMID:18418421 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
decreases expression |
EXP |
Enalapril results in decreased expression of ATP1A3 mRNA; Enalapril results in decreased expression of ATP1A3 protein |
CTD |
PMID:18418421 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
EXP |
Enalapril promotes the reaction [Dexamethasone results in increased activity of AVP protein] |
CTD |
PMID:3346065 |
|
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression |
EXP |
Enalapril results in decreased expression of BAX protein |
CTD |
PMID:21153712 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
EXP |
Enalapril results in increased expression of BCL2 protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] |
CTD |
PMID:21153712 PMID:30623541 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
increases expression multiple interactions |
EXP |
Enalapril results in increased expression of BDKRB1 mRNA [kallidin, des-Arg(10)- results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Enalapril |
CTD |
PMID:18796534 PMID:21430409 |
|
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
increases expression |
EXP |
Enalapril results in increased expression of BDKRB2 mRNA; Enalapril results in increased expression of BDKRB2 protein |
CTD |
PMID:18190998 |
|
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Becn1 |
beclin 1 |
increases expression |
EXP |
Enalapril results in increased expression of BECN1 protein |
CTD |
PMID:30563025 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of BGLAP mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
Enalapril results in decreased activity of CA2 protein |
CTD |
PMID:28126276 |
|
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
EXP |
Enalapril results in decreased activity of CASP3 protein Enalapril inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein] |
CTD |
PMID:21153712 PMID:30623541 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
decreases activity |
EXP |
Enalapril results in decreased activity of CASP9 protein |
CTD |
PMID:21153712 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP |
Enalapril results in increased activity of CAT protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of CAT protein] |
CTD |
PMID:12124199 PMID:30623541 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
EXP ISO |
[paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein Enalapril inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] Enalapril results in decreased expression of CCL2 protein Enalapril results in decreased expression of CCL2 mRNA |
CTD |
PMID:10925121 PMID:17513326 PMID:19627010 PMID:20720404 PMID:25037058 PMID:28973481 More...
|
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of CCN2 mRNA; Enalapril results in decreased expression of CCN2 protein Enalapril inhibits the reaction [Streptozocin results in increased expression of CCN2 protein] |
CTD |
PMID:18812665 PMID:19349682 PMID:21416479 PMID:25037058 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Cela2a |
chymotrypsin like elastase 2A |
decreases expression |
EXP |
Enalapril results in decreased expression of CELA2A mRNA |
CTD |
PMID:21602471 |
|
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
decreases expression |
EXP |
Enalapril results in decreased expression of CLTRN mRNA; Enalapril results in decreased expression of CLTRN protein |
CTD |
PMID:12887829 |
|
NCBI chr X:33,993,825...34,027,124
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Clu |
clusterin |
decreases expression |
EXP |
Enalapril results in decreased expression of CLU protein |
CTD |
PMID:12193663 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cma1 |
chymase 1 |
decreases expression |
EXP |
Enalapril results in decreased expression of CMA1 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr15:33,387,351...33,390,133
Ensembl chr15:29,417,451...29,420,233
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
Enalapril inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA] |
CTD |
PMID:12003776 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression increases expression |
EXP ISO |
Enalapril results in decreased expression of COL3A1 mRNA Enalapril results in increased expression of COL3A1 mRNA |
CTD |
PMID:17164399 PMID:25037058 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions decreases expression |
EXP |
[eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; [eplerenone co-treated with Enalapril] results in decreased expression of COL4A1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of COL4A1 protein; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of COL4A1 mRNA] Enalapril results in decreased expression of COL4A1 mRNA; Enalapril results in decreased expression of COL4A1 protein |
CTD |
PMID:9175058 PMID:18682491 |
|
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Cs |
citrate synthase |
increases activity |
EXP |
Enalapril results in increased activity of CS protein |
CTD |
PMID:30563025 |
|
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions decreases expression |
ISO |
[paricalcitol co-treated with Enalapril] results in decreased expression of CYBA protein Enalapril results in decreased expression of CYBA protein |
CTD |
PMID:20720404 PMID:25037058 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization |
EXP |
Enalapril affects the localization of CYCS protein |
CTD |
PMID:21153712 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] |
CTD |
PMID:19299527 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDN1 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Eng |
endoglin |
multiple interactions |
ISO |
[Enalapril co-treated with paricalcitol] results in decreased expression of ENG mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Epo |
erythropoietin |
decreases expression multiple interactions |
ISO EXP |
Enalapril results in decreased expression of EPO protein Enalapril inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] |
CTD |
PMID:2474097 PMID:9434678 PMID:19958114 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in increased expression of EPOR mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of EPOR protein] |
CTD |
PMID:19958114 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression multiple interactions |
ISO |
Enalapril results in decreased expression of F3 protein Enalapril inhibits the reaction [[Shiga Toxin 1 co-treated with TNF protein] results in increased activity of F3 protein] |
CTD |
PMID:18060435 PMID:22188725 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Faslg |
Fas ligand |
decreases expression |
EXP |
Enalapril results in decreased expression of FASLG mRNA |
CTD |
PMID:10925121 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gh1 |
growth hormone 1 |
increases response to substance |
ISO |
GH1 protein results in increased susceptibility to Enalapril |
CTD |
PMID:12883983 |
|
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
multiple interactions |
ISO |
GJA5 affects the reaction [Enalapril results in increased secretion of REN protein] |
CTD |
PMID:19109587 |
|
NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gjc1 |
gap junction protein, gamma 1 |
multiple interactions |
ISO |
GJC1 affects the reaction [Enalapril results in increased secretion of REN protein] |
CTD |
PMID:19109587 |
|
NCBI chr10:88,262,840...88,285,646
Ensembl chr10:87,760,528...87,785,867
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Isoproterenol results in decreased phosphorylation of GSK3B protein] |
CTD |
PMID:18806606 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Has2 |
hyaluronan synthase 2 |
increases expression |
EXP |
Enalapril results in increased expression of HAS2 mRNA |
CTD |
PMID:20933085 |
|
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
EXP ISO |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of HMGB1 protein] Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of HMGB1 protein] |
CTD |
PMID:19114890 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
Enalapril results in increased expression of HMOX1 protein |
CTD |
PMID:21263376 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hyal1 |
hyaluronidase 1 |
decreases expression |
EXP |
Enalapril results in decreased expression of HYAL1 mRNA; Enalapril results in decreased expression of HYAL1 protein |
CTD |
PMID:20933085 |
|
NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:108,250,667...108,260,210
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of ICAM1 protein Enalapril inhibits the reaction [sodium arsenite results in increased secretion of ICAM1 protein modified form] [Enalapril co-treated with paricalcitol] results in decreased expression of ICAM1 mRNA Enalapril results in decreased expression of ICAM1 protein modified form |
CTD |
PMID:14716214 PMID:17347482 PMID:25037058 PMID:28973481 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression decreases expression |
EXP |
Enalapril affects the expression of IGF1 protein Enalapril results in decreased expression of IGF1 mRNA |
CTD |
PMID:12883983 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression |
EXP |
Enalapril results in increased expression of IGFBP1 mRNA |
CTD |
PMID:12883983 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA protein] |
CTD |
PMID:17299153 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
EXP ISO |
Enalapril inhibits the reaction [Acrolein results in increased expression of IL1B mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of IL1B protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA] Enalapril results in decreased expression of IL1B mRNA |
CTD |
PMID:17167242 PMID:21265103 PMID:25037058 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions affects response to substance |
EXP ISO |
Enalapril inhibits the reaction [Acrolein results in increased expression of IL6 mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of IL6 protein]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of IL6 protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of IL6 protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA] Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of IL6 protein] IL6 gene polymorphism affects the susceptibility to Enalapril |
CTD |
PMID:15342284 PMID:17167242 PMID:19114890 PMID:21265103 PMID:30623541 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Enalapril] results in decreased expression of IRAK1 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Itga2 |
integrin subunit alpha 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of ITGA2 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Cyclosporine results in increased expression of KDR mRNA] |
CTD |
PMID:12110003 |
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kng1 |
kininogen 1 |
increases response to substance |
EXP |
Enalapril results in increased susceptibility to KNG1 protein modified form |
CTD |
PMID:18190998 |
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lamb1 |
laminin subunit beta 1 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:47,835,525...47,902,585
|
|
G |
Lamb2 |
laminin subunit beta 2 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB2 mRNA] |
CTD |
PMID:9175058 |
|
NCBI chr 8:118,056,899...118,069,090
Ensembl chr 8:109,178,409...109,190,549
|
|
G |
Lep |
leptin |
increases response to substance |
ISO |
LEP protein results in increased susceptibility to Enalapril |
CTD |
PMID:20614101 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases expression increases phosphorylation |
EXP |
Enalapril results in increased expression of MAPK9 mRNA; Enalapril results in increased expression of MAPK9 protein Enalapril results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:15531746 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression |
EXP |
Enalapril results in increased expression of MFN2 protein |
CTD |
PMID:30563025 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mir146a |
microRNA 146a |
multiple interactions |
ISO |
[Atorvastatin co-treated with Enalapril] results in decreased expression of MIR146A |
CTD |
PMID:20524934 |
|
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir146b |
microRNA 146b |
multiple interactions |
ISO |
[Atorvastatin co-treated with Enalapril] results in decreased expression of MIR146B |
CTD |
PMID:20524934 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
decreases expression |
ISO |
Enalapril results in decreased expression of MMP3 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased activity of MPO protein] |
CTD |
PMID:19114890 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myh6 |
myosin heavy chain 6 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in decreased expression of MYH6 mRNA]; Enalapril inhibits the reaction [Streptozocin results in decreased expression of MYH6 protein] |
CTD |
PMID:15362513 |
|
NCBI chr15:32,388,102...32,413,663
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Myh7 |
myosin heavy chain 7 |
decreases expression multiple interactions |
EXP |
Enalapril results in decreased expression of MYH7 mRNA Enalapril inhibits the reaction [Streptozocin results in increased expression of MYH7 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of MYH7 protein] |
CTD |
PMID:15362513 PMID:21423293 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in decreased expression of NDST1 protein] |
CTD |
PMID:15793251 |
|
NCBI chr18:56,407,308...56,470,007
Ensembl chr18:54,140,779...54,178,191
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression |
EXP |
Enalapril results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases activity multiple interactions |
EXP |
Enalapril results in decreased activity of NFKB1 protein Enalapril inhibits the reaction [Acrolein results in increased expression of NFKB1 mRNA]; Enalapril inhibits the reaction [Acrolein results in increased expression of NFKB1 protein] |
CTD |
PMID:19225048 PMID:21265102 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased degradation of and results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:19114890 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Noa1 |
nitric oxide associated 1 |
increases expression increases activity |
EXP |
Enalapril results in increased expression of NOA1 mRNA Enalapril results in increased activity of NOA1 protein |
CTD |
PMID:14588141 |
|
NCBI chr14:31,189,570...31,205,600
Ensembl chr14:30,835,247...30,851,293
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of NOS2 protein [paricalcitol co-treated with Enalapril] results in decreased expression of NOS2 protein |
CTD |
PMID:20720404 PMID:21377515 PMID:25037058 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases expression affects expression |
EXP ISO |
[Enalapril co-treated with eplerenone] results in decreased expression of NOS3 mRNA; Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] Enalapril results in increased expression of NOS3 protein [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein; Enalapril inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in decreased expression of NOS3 protein]] Enalapril affects the expression of NOS3 mRNA |
CTD |
PMID:12176110 PMID:16197366 PMID:20571278 PMID:20720404 PMID:25037058 PMID:30940551 More...
|
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
decreases expression |
ISO EXP |
Enalapril results in decreased expression of NPPA protein Enalapril results in decreased expression of NPPA mRNA |
CTD |
PMID:2136812 PMID:8112904 PMID:21423293 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] |
CTD |
PMID:18806606 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases expression |
EXP |
Enalapril results in increased expression of NR3C2 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
EXP |
Enalapril results in increased expression of NRF1 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Pdpn |
podoplanin |
increases expression |
EXP |
Enalapril results in increased expression of PDPN protein |
CTD |
PMID:20933085 |
|
NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:155,601,691...155,635,656
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Enalapril co-treated with Glucose] binds to PPARA protein; Enalapril inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]] |
CTD |
PMID:18812576 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression multiple interactions |
EXP |
Enalapril results in decreased expression of PPARG protein Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] |
CTD |
PMID:19225048 PMID:30623541 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
EXP |
Enalapril results in increased expression of PPARGC1A mRNA |
CTD |
PMID:18765277 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases expression |
EXP |
Enalapril results in increased expression of PRDX3 protein |
CTD |
PMID:30563025 |
|
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases expression |
ISO |
Enalapril results in increased expression of PRKAA1 protein |
CTD |
PMID:25037058 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
EXP |
Enalapril results in decreased expression of PRKCA protein modified form |
CTD |
PMID:21565836 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
ISO |
Enalapril results in decreased expression of PTGS1 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of PTGS2 protein [paricalcitol co-treated with Enalapril] results in decreased expression of PTGS2 protein |
CTD |
PMID:20720404 PMID:21377515 PMID:25037058 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Folic Acid results in decreased expression of PTH1R protein] |
CTD |
PMID:15728788 |
|
NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:110,697,485...110,719,729
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Folic Acid results in increased expression of PTHLH mRNA]; Enalapril inhibits the reaction [Folic Acid results in increased expression of PTHLH protein] |
CTD |
PMID:15728788 |
|
NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Isoproterenol results in increased expression of RELA protein] |
CTD |
PMID:30623541 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
multiple interactions increases expression increases secretion decreases activity increases activity |
ISO EXP |
[Indomethacin co-treated with Enalapril] results in decreased expression of REN protein; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone] Enalapril results in increased expression of REN mRNA; Enalapril results in increased expression of REN protein Enalapril results in increased secretion of REN protein [Sodium Chloride deficiency co-treated with Enalapril] results in increased expression of REN mRNA; GJA5 affects the reaction [Enalapril results in increased secretion of REN protein]; GJC1 affects the reaction [Enalapril results in increased secretion of REN protein]; REN enhancer mutant form results in decreased susceptibility to [Sodium Chloride deficiency co-treated with Enalapril]; Sodium inhibits the reaction [Enalapril results in increased expression of REN mRNA]; Sodium inhibits the reaction [Enalapril results in increased expression of REN protein]; Sodium inhibits the reaction [Enalapril results in increased secretion of REN protein] Enalapril results in decreased activity of REN protein Enalapril results in increased activity of REN protein |
CTD |
PMID:1330361 PMID:2994932 PMID:6094050 PMID:11078175 PMID:12434137 PMID:17846348 PMID:18679781 PMID:18796534 PMID:19109587 PMID:19536436 PMID:19767874 PMID:21423293 PMID:21424707 More...
|
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of RUNX2 mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of RUNX2 mRNA] |
CTD |
PMID:30423288 PMID:31887396 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
Enalapril inhibits the reaction [sodium arsenite results in increased expression of SELE protein] |
CTD |
PMID:28973481 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sell |
selectin L |
multiple interactions |
ISO |
[Enalapril co-treated with paricalcitol] results in decreased expression of SELL mRNA |
CTD |
PMID:25037058 |
|
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Selp |
selectin P |
multiple interactions decreases expression |
EXP ISO |
Enalapril inhibits the reaction [Diclofenac results in decreased expression of SELP protein] Enalapril results in decreased expression of SELP mRNA |
CTD |
PMID:14716214 PMID:25037058 |
|
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Serpinb2 |
serpin family B member 2 |
decreases expression |
ISO |
Enalapril results in decreased expression of SERPINB2 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions decreases expression |
EXP |
[eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; [eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; [eplerenone co-treated with Enalapril] results in decreased expression of SERPINE1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of SERPINE1 protein; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein] Enalapril results in decreased expression of SERPINE1 mRNA; Enalapril results in decreased expression of SERPINE1 protein |
CTD |
PMID:18682491 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] |
CTD |
PMID:18713951 |
|
NCBI chr11:77,519,565...77,548,609
Ensembl chr11:64,014,182...64,043,225
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC22A12 protein results in increased uptake of Uric Acid] |
CTD |
PMID:21272127 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates] |
CTD |
PMID:12065749 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
ISO |
Enalapril inhibits the reaction [SLC22A8 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:15100168 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
Enalapril promotes the reaction [paricalcitol results in decreased phosphorylation of SMAD2 protein] |
CTD |
PMID:17513326 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad7 |
SMAD family member 7 |
increases expression |
EXP |
Enalapril results in increased expression of SMAD7 mRNA; Enalapril results in increased expression of SMAD7 protein |
CTD |
PMID:19197123 PMID:19349682 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases expression |
ISO |
[paricalcitol co-treated with Enalapril] results in increased expression of SOD1 protein Enalapril results in increased expression of SOD1 protein |
CTD |
PMID:20720404 PMID:25037058 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases activity increases expression decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased activity of SOD2 protein Enalapril results in increased expression of SOD2 protein Enalapril results in decreased expression of SOD2 protein [paricalcitol co-treated with Enalapril] results in decreased expression of SOD2 protein |
CTD |
PMID:18765277 PMID:20720404 PMID:25037058 PMID:30563025 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
ISO EXP |
[Enalapril co-treated with paricalcitol] results in decreased expression of SPP1 mRNA Enalapril inhibits the reaction [Corticosterone results in decreased expression of SPP1 mRNA]; Enalapril inhibits the reaction [Ethanol results in decreased expression of SPP1 mRNA] |
CTD |
PMID:25037058 PMID:30423288 PMID:31887396 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
EXP |
Enalapril results in increased expression of SQSTM1 protein |
CTD |
PMID:30563025 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
increases expression |
EXP |
Enalapril results in increased expression of SSBP1 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:69,266,102...69,276,135
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in increased expression of STAT3 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of STAT3 protein] |
CTD |
PMID:19958114 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tek |
TEK receptor tyrosine kinase |
multiple interactions |
EXP |
Enalapril inhibits the reaction [Streptozocin results in increased expression of TEK mRNA] |
CTD |
PMID:19958114 |
|
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases expression |
EXP |
Enalapril results in increased expression of TFAM protein |
CTD |
PMID:30563025 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
EXP |
[eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; [eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; [eplerenone co-treated with Enalapril] results in decreased expression of TGFB1 mRNA; [eplerenone co-treated with Enalapril] results in decreased expression of TGFB1 protein; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]; Enalapril promotes the reaction [paricalcitol results in decreased expression of TGFB1 mRNA]; Enalapril promotes the reaction [paricalcitol results in decreased expression of TGFB1 protein] Enalapril results in decreased expression of TGFB1 mRNA; Enalapril results in decreased expression of TGFB1 protein |
CTD |
PMID:12883979 PMID:15309289 PMID:17164399 PMID:17513326 PMID:18682491 PMID:19197123 PMID:19349682 PMID:23733546 More...
|
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
EXP |
Enalapril results in decreased expression of TGFB2 mRNA |
CTD |
PMID:17164399 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
decreases secretion multiple interactions |
EXP |
Enalapril results in decreased secretion of TGFBI protein [eplerenone co-treated with Enalapril] results in decreased secretion of TGFBI protein |
CTD |
PMID:18682491 |
|
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
decreases expression |
EXP |
Enalapril results in decreased expression of TGFBR1 mRNA; Enalapril results in decreased expression of TGFBR1 protein |
CTD |
PMID:12883979 |
|
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Thbs4 |
thrombospondin 4 |
increases expression |
ISO |
Enalapril results in increased expression of THBS4 mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 2:23,983,158...24,025,289
Ensembl chr 2:23,983,158...24,026,313
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Enalapril] results in decreased expression of TLR4 mRNA; [Atorvastatin co-treated with Enalapril] results in decreased expression of TLR4 protein |
CTD |
PMID:20524934 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
EXP ISO |
Enalapril results in decreased expression of TNF protein Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased expression of TNF protein]; Enalapril inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; Enalapril inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] [paricalcitol co-treated with Enalapril] results in decreased expression of TNF protein; Enalapril inhibits the reaction [Bleomycin results in increased expression of TNF mRNA]; Enalapril inhibits the reaction [endotoxin, Escherichia coli results in increased secretion of TNF protein] Enalapril inhibits the reaction [[Shiga Toxin 1 co-treated with TNF protein] results in increased activity of F3 protein]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA protein] |
CTD |
PMID:12003776 PMID:16336586 PMID:17167242 PMID:17299153 PMID:18060435 PMID:19114890 PMID:19225048 PMID:20720404 PMID:25037058 PMID:30623541 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tomm20 |
translocase of outer mitochondrial membrane 20 |
decreases expression |
EXP |
Enalapril results in decreased expression of TOMM20 mRNA |
CTD |
PMID:18765277 |
|
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:54,923,402...54,935,198
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Enalapril] results in decreased expression of TRAF6 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
affects expression decreases expression |
ISO |
Enalapril affects the expression of VCAM1 Enalapril results in decreased expression of VCAM1 mRNA; Enalapril results in decreased expression of VCAM1 protein modified form |
CTD |
PMID:17347482 PMID:19939336 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
EXP ISO |
Enalapril inhibits the reaction [Cyclosporine results in increased expression of VEGFA protein] Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [IL1A protein results in increased expression of VEGFA protein]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; Enalapril inhibits the reaction [TNF protein results in increased expression of VEGFA protein]; Enalapril inhibits the reaction [VEGFA protein results in increased expression of VEGFA mRNA] Enalapril results in increased expression of VEGFA protein |
CTD |
PMID:12110003 PMID:16202860 PMID:17299153 PMID:21263376 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vwf |
von Willebrand factor |
decreases expression |
ISO |
Enalapril results in decreased expression of VWF mRNA |
CTD |
PMID:25037058 |
|
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
|
|
|
G |
Ace |
angiotensin I converting enzyme |
multiple interactions |
ISO |
Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein] |
CTD |
PMID:16452552 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
affects expression |
EXP |
Enalaprilat affects the expression of ADRB1 protein |
CTD |
PMID:9260993 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
affects expression |
EXP |
Enalaprilat affects the expression of ADRB2 protein |
CTD |
PMID:9260993 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Agt |
angiotensinogen |
decreases expression multiple interactions |
EXP ISO |
Enalaprilat results in decreased expression of AGT protein modified form Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein] |
CTD |
PMID:16452552 PMID:21795644 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein] |
CTD |
PMID:16452552 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
Enalaprilat results in increased expression of BCL2 mRNA |
CTD |
PMID:17342403 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
multiple interactions increases activity |
ISO |
bradykinin, Lys-Leu(8)-desArg(9)- inhibits the reaction [Enalaprilat results in increased activity of BDKRB1 protein]; Zinc affects the reaction [Enalaprilat results in increased activity of BDKRB1 protein] |
CTD |
PMID:11880373 |
|
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Edn1 |
endothelin 1 |
decreases secretion |
ISO |
Enalaprilat results in decreased secretion of EDN1 protein |
CTD |
PMID:19079593 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression multiple interactions |
EXP ISO |
Enalaprilat results in decreased expression of FN1 mRNA; Enalaprilat results in decreased expression of FN1 protein Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA] |
CTD |
PMID:14520012 PMID:21795644 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
multiple interactions |
EXP |
Enalaprilat inhibits the reaction [Dexamethasone results in decreased expression of GLUD1 mRNA]; Enalaprilat inhibits the reaction [Dexamethasone results in decreased expression of GLUD2 mRNA] |
CTD |
PMID:32494933 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Grm1 |
glutamate metabotropic receptor 1 |
multiple interactions |
EXP |
Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of GRM1 mRNA] |
CTD |
PMID:32494933 |
|
NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:5,058,292...5,453,170
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
EXP |
Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of HMGB1 mRNA]; Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of HMGB1 protein] |
CTD |
PMID:32494933 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Enalaprilat inhibits the reaction [Glucose results in decreased secretion of INS protein] |
CTD |
PMID:16452552 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
EXP |
[Enalaprilat co-treated with Daunorubicin] results in increased expression of PPARD mRNA |
CTD |
PMID:23834779 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Ren |
renin |
increases expression |
EXP |
Enalaprilat results in increased expression of REN mRNA |
CTD |
PMID:21795644 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression |
EXP |
Enalaprilat results in decreased expression of SERPINE1 mRNA |
CTD |
PMID:21795644 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions increases uptake |
ISO |
verlukast inhibits the reaction [SLC22A8 protein results in increased uptake of Enalaprilat] |
CTD |
PMID:33007874 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
Enalaprilat results in decreased expression of TGFB1 mRNA; Enalaprilat results in decreased expression of TGFB1 protein |
CTD |
PMID:21795644 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of TLR4 mRNA] |
CTD |
PMID:32494933 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression |
ISO |
Enalaprilat results in decreased expression of TNF mRNA |
CTD |
PMID:17342403 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|